Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Tern plc ( (GB:TERN) ) is now available.
Tern Plc has announced the extension of the maturity dates for approximately £0.3 million of convertible loan notes in Talking Medicines Limited to 21 November 2029. This strategic move is expected to enhance Tern’s negotiating position for a potential exit from its investment in Talking Medicines, aligning the terms of the loan notes with previous agreements.
The most recent analyst rating on (GB:TERN) stock is a Hold with a £0.50 price target. To see the full list of analyst forecasts on Tern plc stock, see the GB:TERN Stock Forecast page.
Spark’s Take on GB:TERN Stock
According to Spark, TipRanks’ AI Analyst, GB:TERN is a Neutral.
Tern plc’s overall stock score is primarily impacted by its poor financial performance, characterized by declining revenue and negative profitability. Technical analysis also indicates a bearish trend, further weighing down the score. The valuation is unattractive due to the negative P/E ratio and lack of dividend yield. The absence of earnings call and corporate events data means these factors do not influence the score.
To see Spark’s full report on GB:TERN stock, click here.
More about Tern plc
Tern Plc is an investment company that focuses on supporting high growth, early-stage, disruptive Internet of Things (IoT) technology businesses.
Average Trading Volume: 2,382,758
Technical Sentiment Signal: Sell
Current Market Cap: £3.03M
For detailed information about TERN stock, go to TipRanks’ Stock Analysis page.